Fresh Patents navbar
Monitor Patents Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents Browse Locations

PFE - Pfizer Inc. patents

This listing is of recent patents (patent applications) which may be related to Pfizer Inc. according to a patent app search. In *most* cases, they are listed under Pfizer Inc. because the company is listed in the Agent field of the patent application. Note: Pfizer Inc. (PFE) may have other listings under a different name, spelling or agent. If there is another company with a similar name, it's possible their patents could be inadvertantly included here. Notify us of any issues. Also, FreshPatents.com is not affiliated with Pfizer Inc., we're just tracking patents related to them as published publically by the USPTO. Full list of Stock Symbols and Company RSS Feeds

SUBSCRIBE to updates on this page: Pfizer Inc. patents RSS Feed (FREE) RSS

P

PANL
PBI
PDII
PDLI
PEP
PFE
PGNX
PKI
PLT
PPG
PPHM
PTEC
PTN
PTV
PX
Symbol Company Application # Date Title
PFE Pfizer 20130121923 20130516 Treatment of male sexual dysfunction
PFE Pfizer 20130116285 20130509 Chemical compounds
PFE Pfizer 20130109670 20130502 Triazine compounds as pi3 kinase and mtor inhibitors
PFE Pfizer 20130109696 20130502 Chemical compounds
PFE Pfizer 20130109701 20130502 Chemical compounds
PFE Pfizer 20130109708 20130502 Chemical compounds
PFE Pfizer 20130079324 20130328 Pyrrolopyrimidine and purine derivatives
PFE Pfizer 20130078270 20130328 Her-2 peptides and vaccines
PFE Pfizer 20130078240 20130328 4-1bb binding molecules
PFE Pfizer 20130071921 20130321 Antibodies specific for dkk-1 and their uses
PFE Pfizer 20130072427 20130321 Gpr 119 modulators
PFE Pfizer 20130030181 20130131 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
PFE Pfizer 20130029968 20130131 Indazoles
PFE Pfizer 20130029377 20130131 Recombinant apoa-1m from engineered bacteria
PFE Pfizer 20130022616 20130124 Interleukin-31 monoclonal antibody
PFE Pfizer 20120328639 20121227 Immunogenic lhrh compositions and methods relating thereto
PFE Pfizer 20120329724 20121227 Peptide analogues
PFE Pfizer 20120329777 20121227 Amino-heterocyclic compounds
PFE Pfizer 20120329781 20121227 Combinations comprising alpha-2-delta ligands
PFE Pfizer 20120321651 20121220 Anti-ige vaccines
PFE Pfizer 20120321654 20121220 Infectious clones of torque teno virus
PFE Pfizer 20120322782 20121220 Veterinary compositions
PFE Pfizer 20120322823 20121220 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
PFE Pfizer 20120316210 20121213 Topical antiparasitic formulations
PFE Pfizer 20120316150 20121213 Amide compounds useful in therapy
PFE Pfizer 20120316105 20121213 Polymyxin derivates useful as antibacterial agents
PFE Pfizer 20120315271 20121213 Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
PFE Pfizer 20120309775 20121206 4-methylpyridopyrimidinone compounds
PFE Pfizer 20120298107 20121129 Dispensing device
PFE Pfizer 20120302542 20121129 Monobactams
PFE Pfizer 20120302550 20121129 Salts and polymorphs of 8-fluoro-2--1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
PFE Pfizer 20120302599 20121129 Kat ll inhibitors
PFE Pfizer 20120302598 20121129 Imidazopyridinones
PFE Pfizer 20120291782 20121122 Device for dispensing a plurality of unitary doses of dry powder, and inhaler comprising such device
PFE Pfizer 20120294848 20121122 Ige ch3 peptide vaccine
PFE Pfizer 20120295845 20121122 Imidazo-pyrazoles as gpr119 inhibitors
PFE Pfizer 20120295923 20121122 Aminocyclohexanes and aminotetrahydropyrans and related compounds as gamma-secretase modulators
PFE Pfizer 20120289576 20121115 Process for forming amorphous atorvastatin
PFE Pfizer 20120289455 20121115 Monocarbams
PFE Pfizer 20120283237 20121108 Novel cephalosporins useful as antibacterial agents
PFE Pfizer 20120282279 20121108 Anti-diabetic compounds
PFE Pfizer 20120279908 20121108 A method for detecting a malfunctioning egg picker
PFE Pfizer 20120270893 20121025 Substituted acetyl-coa carboxylase inhibitors
PFE Pfizer 20120264934 20121018 Salt forms of [r-(r*,r*)]-2-(4-flurorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
PFE Pfizer 20120263732 20121018 Cd40 antibody formulation and methods
PFE Pfizer 20120263677 20121018 Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
PFE Pfizer 20120258948 20121011 N-linked hydroxamic acid derivatives useful as antibacterial agents
PFE Pfizer 20120258950 20121011 Pyrrolo[2,3-d]pyrimidine tropomysin-related kinase inhibitors
PFE Pfizer 20120258976 20121011 Crystalline pyrrolo[2,3-d]pyrimidine compounds
PFE Pfizer 20120259115 20121011 Pyrrolo[2,3-d]pyrimidine derivatives: their intermediates and synthesis
PFE Pfizer 20120252825 20121004 Beneficial effects of combination therapy on cholesterol
PFE Pfizer 20120251566 20121004 Saponin adjuvant compositions and methods relating thereto
PFE Pfizer 20120237498 20120920 4-1bb binding molecules
PFE Pfizer 20120232026 20120913 Spirocyclic isoxazoline derivatives as antiparasitic agents
PFE Pfizer 20120232083 20120913 Fluoro-pyridinone derivatives useful as antibacterial agents
PFE Pfizer 20120225910 20120906 Substituted heteroaryls
PFE Pfizer 20120225900 20120906 N2-pyrazolospiroketone acetyl-coa carboxylase inhibitors
PFE Pfizer 20120220568 20120830 Histamine-3 receptor antagonists
PFE Pfizer 20120213793 20120823 Cancer treatment
PFE Pfizer 20120214791 20120823 Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
PFE Pfizer 20120214827 20120823 Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
PFE Pfizer 20120208830 20120816 Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
PFE Pfizer 20120207712 20120816 Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
PFE Pfizer 20120202285 20120809 Antibodies to il-6 and their uses
PFE Pfizer 20120202787 20120809 Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators
PFE Pfizer 20120202809 20120809 Novel n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as pkc kinase inhibitors
PFE Pfizer 20120202834 20120809 Glucagon receptor modulators
PFE Pfizer 20120184486 20120719 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
PFE Pfizer 20120171284 20120705 Celecoxib compositions
PFE Pfizer 20120165343 20120628 Glucagon receptor modulators
PFE Pfizer 20120157440 20120621 Novel fused pyridine compounds as casein kinase inhibitors
PFE Pfizer 20120157471 20120621 Benzimidazole derivatives
PFE Pfizer 20120157502 20120621 Phenanthrenone compounds, compositions and methods
PFE Pfizer 20120149679 20120614 Sulfonamide derivatives
PFE Pfizer 20120142729 20120607 Kat ll inhibitors
PFE Pfizer 20120142749 20120607 Solid salt forms of a pyrrole substituted 2-indolinone
PFE Pfizer 20120122901 20120517 Pyrrolo[2,3-d]pyrimidine compounds
PFE Pfizer 20120111327 20120510 Does unit, pack of dose units and inhaler for inhalation of combination of drugs
PFE Pfizer 20120108619 20120503 N1/n2-lactam acetyl-coa carboxylase inhibitors
PFE Pfizer 20120108588 20120503 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h, 4h,6h) carbaldehyde derivatives
PFE Pfizer 20120107871 20120503 Method of producing human igg antibodies with enhanced effector functions
PFE Pfizer 20120107351 20120503 In ovo vaccination of campylobacter in avian species
PFE Pfizer 20120093813 20120419 Anti notch-1 antibodies
PFE Pfizer 20120095006 20120419 Treatment of pulmonary hypertension
PFE Pfizer 20120095028 20120419 3-oxa-7-azabicyclo[3.3.1]nonanes
PFE Pfizer 20120095062 20120419 Tricyclic compounds, compositions, and methods
PFE Pfizer 20120088802 20120412 Tricyclic compounds, compositions and methods
PFE Pfizer 20120087978 20120412 Dosage forms of apixaban
PFE Pfizer 20120077765 20120329 Isoxazoline oximes as antiparasitic agents
PFE Pfizer 20120065188 20120315 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
PFE Pfizer 20120065265 20120315 Alpha-2-delta ligands for non-restorative sleep
PFE Pfizer 20120059040 20120308 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid magnesium
PFE Pfizer 20120053165 20120301 Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
PFE Pfizer 20120052130 20120301 Gpr 119 modulators
PFE Pfizer 20120039908 20120216 Control of protein glycosylation and compositions and methods relating thereto
PFE Pfizer 20120041026 20120216 (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
PFE Pfizer 20120035209 20120209 Hydroxy substituted 1h-imidazopyridines and methods
PFE Pfizer 20120035194 20120209 Substituted 2-amino-fused heterocyclic compounds
PFE Pfizer 20120035131 20120209 Pyrazoline compounds
PFE Pfizer 20120029192 20120202 Pyrazole derivatives
PFE Pfizer 20120020995 20120126 Parapoxvirus vectors
PFE Pfizer 20120021001 20120126 Marked bovine viral diarrhea virus vaccines
PFE Pfizer 20120022058 20120126 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
PFE Pfizer 20120015412 20120119 Preparation of pregabalin and related compounds
PFE Pfizer 20120010182 20120112 Chemical compounds
PFE Pfizer 20120010183 20120112 Chemical compounds
PFE Pfizer 20120010207 20120112 Chemical compounds
PFE Pfizer 20120003179 20120105 Anti-ctla-4 and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
PFE Pfizer 20110300163 20111208 Ige ch3 peptide vaccine
PFE Pfizer 20110300174 20111208 Conjugates for the prevention or treatment of nicotine addiction
PFE Pfizer 20110300212 20111208 Pharmaceutical formulation
PFE Pfizer 20110301358 20111208 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylmino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1)
PFE Pfizer 20110294826 20111201 Pyrrolo[2,3-d]pyrimidine compounds
PFE Pfizer 20110294751 20111201 High dosage doramectin formulation
PFE Pfizer 20110293647 20111201 Immunogenic lhrh compositions and methods relating thereto
PFE Pfizer 20110287051 20111124 Parapoxvirus vectors
PFE Pfizer 20110288297 20111124 Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
PFE Pfizer 20110281854 20111117 Morpholine compounds
PFE Pfizer 20110274696 20111110 Antibodies to ccr2
PFE Pfizer 20110262909 20111027 Genetic markers for horned and polled cattle and related methods
PFE Pfizer 20110257371 20111020 Methods of treating chronic pain




###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Pfizer Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pfizer Inc. with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###

Design/code © 2008 FreshContext LLC/Freshpatents.com. Website Terms and Conditions